Sabby Management, LLC
- SEC CIK
- 0001535610
- Latest filing
- Aug 14, 2026
COCP holding history
Cocrystal Pharma, Inc. in every 13F filed by Sabby Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
COCP overviewAll 13F holders of COCPFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −66,172−100.0% | Sold out | Holders |
| Q1 2023 | 66,172 | $131.7K | 0.5% | −354,538−84.3% | Reduced | Holders |
| Q4 2022 | 420,710 | $820.4K | 2.2% | −19,645−4.5% | ReducedConverted for a 1-for-12 split | Holders |
| Q3 2022 | 5,284,256 | $1.54M | 3.3% | −604,671−10.3% | Reduced | Holders |
| Q2 2022 | 5,888,927 | $2.41M | 4.5% | +276,890+4.9% | Added | Holders |
| Q1 2022 | 5,612,037 | $3.09M | 1.3% | −126,083−2.2% | Reduced | Holders |
| Q4 2021 | 5,738,120 | $3.73M | 0.9% | +572,704+11.1% | Added | Holders |
| Q3 2021 | 5,165,416 | $5.42M | 1.2% | −945,241−15.5% | Reduced | Holders |
| Q2 2021 | 6,110,657 | $7.64M | 1.7% | +6,110,657 | New | Holders |